Literature DB >> 23399999

Breast cancer: ALTTO: wake-up call for setting up clinical trials.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2013        PMID： 23399999     DOI： 10.1038/nrclinonc.2013.20

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  The clinical trials system is broken.

Authors:  Vincent T DeVita
Journal:  Nat Clin Pract Oncol       Date:  2008-12

2.  Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.

Authors:  Otto Metzger-Filho; Evandro de Azambuja; Ian Bradbury; Kamal S Saini; José Bines; Sergio D Simon; Veerle Van Dooren; Gursel Aktan; Kathleen I Pritchard; Antonio C Wolff; Ian Smith; Christian Jackisch; Istvan Lang; Michael Untch; Frances Boyle; Binghe Xu; Jose Baselga; Edith A Perez; Martine Piccart-Gebhart
Journal:  Oncologist       Date:  2013-01-28
  2 in total
  3 in total

1.  Risk factors: Cachexia--skeletal muscle depletion is a prognostic factor.

Authors:  Lisa Hutchinson
Journal:  Nat Rev Clin Oncol       Date:  2013-04-09       Impact factor: 66.675

Review 2.  Progress in adjuvant chemotherapy for breast cancer: an overview.

Authors:  Jesus Anampa; Della Makower; Joseph A Sparano
Journal:  BMC Med       Date:  2015-08-17       Impact factor: 8.775

3.  Clinicopathological characteristics of patients with HER2-positive breast cancer and the efficacy of trastuzumab in the People's Republic of China.

Authors:  Ping Zhou; Yi-Zhou Jiang; Xin Hu; Wei Sun; Yi-Rong Liu; Fang Liu; Rong-Cheng Luo; Zhi-Ming Shao
Journal:  Onco Targets Ther       Date:  2016-04-18       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.